Skip to content
Recall Observatory FDA recall evidence

Drug product

Ceftriaxone for Injection USP, 2 g, packaged in 10 Single Use Vials (NDC 68180-644-01) per box, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., 111 South Calvert Street, Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-644-10.

D-0358-2019

December 20, 2018

Class I

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 81796
Status
Terminated
Classification
Class I
Quantity
3,792 boxes
Official record key
drug-enforcement:D-0358-2019

Official wording

Reason: Presence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted vials.

Code information: Lot #: C600109, Exp 05/19; C600129, C600135, Exp 08/19

Distribution pattern: Nationwide in the USA and Puerto Rico.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Particulate Matter